Skip to main content
Clinical Trials/NCT03978260
NCT03978260CompletedNot Applicable

Preoperative Anaemia Prevalence in Surgical Patients- A Prospective, International, Multicentre Observational Study (ALICE)

Johann Wolfgang Goethe University Hospital1 site in 1 country2,500 target enrollmentStarted: August 15, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
2,500
Locations
1
Primary Endpoint
Prevalence of preoperative anaemia

Study Overview

Brief Summary

Preoperative anaemia is common in surgery, with a prevalence between 10 and 50 %, and is an independent risk factor for morbidity and mortality.

Anaemia is mostly the result of an inadequate erythropoiesis due to iron deficiency, lack of vitamin B12 or folate, and bone marrow diseases. Among the elderly, renal disease and chronic inflammation account for approximately one-third of all anaemia incidences. The aim of this study is to provide detailed data about the prevalence of preoperative deficiencies in iron, vitamin B12 and/or folate and the presence of underlying renal or chronic diseases in patients undergoing major surgery.

Detailed Description

Preoperative anaemia is common in surgery, with a prevalence between 10 and 50 %, and is an independent risk factor for morbidity and mortality. Due to the potential risk of additional blood loss, anaemia represents a serious disease condition within the surgical field. Especially patients undergoing major elective surgery are at risk of substantial blood loss. Anaemia is mostly the result of an inadequate erythropoiesis due to iron deficiency, lack of vitamin B12 or folate, and bone marrow diseases. Among the elderly, renal disease and chronic inflammation account for approximately one-third of all anaemia incidences. The aim of this study is to provide detailed data about the prevalence of preoperative deficiencies in iron, vitamin B12 and/or folate and the presence of underlying renal or chronic diseases in patients undergoing major surgery. Results will facilitate design of supplementation strategies to improve haemoglobin level before surgery.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 18 years
  • Written informed consent prior to study participating according to the national law requirements
  • Patients undergoing major surgery
  • Expected hospital stay with a minimum of 24 hours

Exclusion Criteria

  • Preoperative autologous blood donation
  • Patients with expected re-surgery within the planned 7-day recruitment period

Outcomes

Primary Outcomes

Prevalence of preoperative anaemia

Time Frame: prior surgery

Hemoglobin level

Secondary Outcomes

  • Re-admission(up to 90 days after discharge)
  • Number of patients with red blood cell transfusion(30 day)
  • Number of patient with revision(90 day)
  • Number of patients with mortality(90 day)
  • Hospital and ICU length of stay(30 days)
  • Incidence of hospital-acquired anaemia(30 days)

Investigators

Sponsor
Johann Wolfgang Goethe University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr. Patrick Meybohm, M.D.

Principal Investigator

Wuerzburg University Hospital

Study Sites (1)

Loading locations...

Similar Trials